3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
4
Stomach Neoplasms
3
Gastrointestinal Neoplasms
3
Rectal Neuroendocrine Tumors
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Small Size Gastrointestinal Stromal Tumors
1
Precancerous Conditions
1
Hemorrhage
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Polyps
1
Clinical Stage III Gastric Cancer AJCC v8
1
Benign Colon Tumors
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
243
Carboplatin
211
Pemetrexed
177
Cisplatin
131
Paclitaxel
113
Nivolumab
101
Docetaxel
87
osimertinib
85
durvalumab
78
Specimen Handling
56
atezolizumab
55
Gemcitabine
52
Drug Therapy
52
Magnetic Resonance Spectroscopy
50
Radiosurgery
48
Radiotherapy
47
Ipilimumab
41
130-nm albumin-bound paclitaxel
39
cemiplimab
38
Bevacizumab
34
Cetuximab
30
tislelizumab
29
amivantamab
22
Taxes
22
Platinum Compounds
20
Blood Specimen Collection
20
Immunotherapy
18
Immune Checkpoint Inhibitors
18
Radiation
17
Erlotinib Hydrochloride
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Non-Small-Cell Lung
×
Endoscopic Mucosal Resection
×
1 year
×
Clear all
No trials found.